Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy - Discussion

被引：0
|
作者：
Levine, E
Loggie, BW
机构：
来源：
AMERICAN SURGEON | 1997年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [31] Combined-modality Therapy for Rectal Cancer Analysis of Potential Differences in Disease Presentation, Treatment Adherence, and Treatment Outcome According to Race
    Tonlaar, Nathan
    Song, Suisui
    Hong, Julian C.
    Minsky, Bruce D.
    Chang, Daniel T.
    Polite, Blase N.
    Liauw, Stanley L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (02): : 122 - 125
  • [32] TREATMENT EVALUATION OF COMBINED-MODALITY THERAPY - WHAT CAN WE OBTAIN TODAY FROM PHASE-II TRIALS
    THATCHER, N
    LUNG CANCER, 1994, 10 : S117 - S133
  • [33] Clinical study of intraperitoneal injection bevacizumab (BV) combined with intraperitoneal hyperthermic perfusion chemotherapy (CT) in treatment of malignant ascites of ovarian cancer (OC)
    Zhao, Hui
    Du, Nan
    Fu, Yan
    Wang, Haibin
    Fan, Zhongyi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] MASSIVE CHEST-WALL TUMOR DIAGNOSED AS ASKIN TUMOR - SUCCESSFUL TREATMENT BY INTENSIVE COMBINED-MODALITY THERAPY IN AN ADULT
    TAKAHASHI, K
    DAMBARA, T
    UEKUSA, T
    NUKIWA, T
    KIRA, S
    CHEST, 1993, 104 (01) : 287 - 288
  • [35] Successful intraperitoneal rituximab treatment in a patient with therapy-resistant malignant ascites due to mantle cell lymphoma
    Charlott Mörth
    Hans Hagberg
    Annals of Hematology, 2015, 94 : 1757 - 1758
  • [36] Successful intraperitoneal rituximab treatment in a patient with therapy-resistant malignant ascites due to mantle cell lymphoma
    Morth, Charlott
    Hagberg, Hans
    ANNALS OF HEMATOLOGY, 2015, 94 (10) : 1757 - 1758
  • [37] Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: What is now the appropriate distal resection margin? Discussion
    Remzi, FH
    Hurst, RD
    Rakinic, J
    Sauter, ER
    SURGERY, 2005, 138 (04) : 663 - 664
  • [38] Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy
    Shilkrut, Mark
    McLaughlin, Patrick W.
    Merrick, Gregory S.
    Vainshtein, Jeffrey M.
    Hamstra, Daniel A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (02): : 181 - 188
  • [39] Combined-modality treatment of esophageal and head and neck cancer using paclitaxel/carboplatin-based chemotherapy concurrently with radiation therapy
    Hainsworth, JD
    Burris, HA
    Meluch, AA
    Greco, FA
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 62 - 62
  • [40] Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study
    Jeremic, B
    Shibamoto, Y
    Nikolic, N
    Milicic, B
    Milisavljevic, S
    Dagovic, A
    Aleksandrovic, J
    Radosavljevic-Asic, G
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 2092 - 2099
12345